Zivo Bioscience Receives Delisting Notice
Ticker: ZIVOW · Form: 8-K · Filed: Feb 15, 2024 · CIK: 1101026
| Field | Detail |
|---|---|
| Company | Zivo Bioscience, Inc. (ZIVOW) |
| Form Type | 8-K |
| Filed Date | Feb 15, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, regulatory-filing, non-compliance
TL;DR
**Zivo Bioscience just got a delisting notice, signaling major trouble for its stock's exchange status.**
AI Summary
Zivo Bioscience, Inc. filed an 8-K on February 15, 2024, reporting an event that occurred on February 13, 2024. The filing, under Item Information: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, indicates the company's non-compliance with exchange listing requirements. This suggests the company is facing potential removal from its current stock exchange.
Why It Matters
A delisting notice signals that Zivo Bioscience, Inc. has failed to meet exchange listing standards, which can lead to its stock being removed from a major exchange, severely impacting liquidity and investor confidence.
Risk Assessment
Risk Level: high — Delisting typically results in a significant loss of liquidity and investor confidence, often leading to a sharp decline in share price and making it harder for investors to trade the stock.
Key Players & Entities
- Zivo Bioscience, Inc. (company) — registrant
- February 13, 2024 (date) — date of earliest event reported
- February 15, 2024 (date) — filing date
- Nevada (location) — state of incorporation
- SEC (company) — regulatory body
FAQ
What is the exact name of the registrant specified in its charter?
The exact name of the registrant is ZIVO BIOSCIENCE, INC.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 13, 2024.
What is the primary item information reported in this 8-K?
The primary item information is 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.'
In which state is Zivo Bioscience, Inc. incorporated?
Zivo Bioscience, Inc. is incorporated in Nevada.
What is the business address of Zivo Bioscience, Inc. as stated in the filing?
The business address is 21 East Long Lake Road, Suite 100, Bloomfield Hills, Michigan 48304.
Filing Stats: 539 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-02-15 16:45:37
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ZIVO OTCQB Warrants to p
Filing Documents
- zivo_8k.htm (8-K) — 23KB
- 0001654954-24-001856.txt ( ) — 140KB
- zivo-20240213.xsd (EX-101.SCH) — 6KB
- zivo-20240213_lab.xml (EX-101.LAB) — 14KB
- zivo-20240213_cal.xml (EX-101.CAL) — 1KB
- zivo-20240213_pre.xml (EX-101.PRE) — 9KB
- zivo-20240213_def.xml (EX-101.DEF) — 2KB
- zivo_8k_htm.xml (XML) — 4KB
01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, The Nasdaq Stock Market LLC (" Nasdaq ") suspended trading in the common stock and warrants of Zivo Bioscience, Inc. (the " Company ") on November 27, 2023 due to previously disclosed noncompliance with Nasdaq Listing Rule 5550(b)(1). On February 13, 2024, Nasdaq announced that it will formally delist the common stock and warrants of the Company that were suspended on November 27, 2023 and file a Form 25 Notification of Delisting with the Securities and Exchange Commission. Beginning November 27, 2023, the Company's common stock had been trading over the counter on the OTC Markets' Pink Sheets, and since January 26, 2024 the Company's common stock has been trading over the counter on the OTCQB market tier, an electronic quotation service operated by OTC Markets Group Inc., under its current trading symbol ZIVO. Similarly, since November 27, 2023, the Company's warrants are traded over the counter on the OTC Markets' Pink Sheets market tier under its current trading symbol ZIVOW. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZIVO BIOSCIENCE, INC. By: /s/ Keith Marchiando Keith Marchiando Chief Financial Officer Date: February 15, 2024 3